Abstract
Introduction
1 Preeclampsia plus seizures after delivery is defined as postpartum eclampsia. Postpartum eclampsia represents anywhere from 11% to 44% of all cases of eclampsia. Postpartum preeclampsia is the occurrence of hypertension and proteinuria after delivery. Preeclampsia plus seizures after delivery is defined as postpartum eclampsia. Postpartum eclampsia is a rare, frightening, and potentially tragic complication of hypertensive pregnancies, usually developing within 48 hours of delivery. Although the overall incidence of preeclampsia seems to have been relatively stable over the last six decades, the incidence of eclampsia has decreased, pre-sumably due to earlier recognition and more aggressive management of preeclampsia in the antepartum and in-trapartum periods. Postpartum eclampsia represents any-where from 11% to 44% of all cases of eclampsia [1] [2] [3] . Postpartum *Corresponding author's Contact: 022-3816463, 0300-3058246 (ORCID ID: 0000-0000-0000-0000): DOI: https://doi.org/10.14741/ijmcr/v.7.3.16 preeclampsia/eclampsia can develop up to 4 weeks after delivery [4] . Because there has been no decrease in the incidence of postpartum eclampsia during the last six decades, an increased proportion of eclamptic seizures occur in the postpartum period [5] .
Postpartum eclampsia is a rare, frightening, and potentially tragic complication of hypertensive pregnancies, usually developing within 48 hours of delivery. Seizures occurring days to weeks after parturition are exceedingly uncommon and require rapid, precise clinical evaluation by multiplespecialists [6, 7] . Seventy-six women had postpartum eclampsia, representing an incidence of 1.0/10 000. Among the women having postpartum eclampsia, 70% occurred in the first 12 hours following delivery, 11%; during hours 12-24, 5%; during the 24-48 hours after delivery and 14% more than 48 hours after delivery, the cesarean delivery rate was higher in women with delayed eclampsia in comparison with earlier postpartum eclampsia 57%. The reported prevalence of de novo postpartum hypertension or preeclampsia ranges from 0.3-27.5% [8] . Recent study on postpartum eclampsia showed that 152 patients who are readmitted to the hospital with diagnosis of postpartum eclampsia, out of them 23.3% of the patients were primigravid, 32.9% were nulliparous. The mode of delivery was vaginal in 57.9% whereas 42.1% underwent cesarean deliveries. 4.6% had gestational hypertension, 9.2%, had chronic hypertension and 18.4%, had preeclampsia.4 Maternal death occurred in women is mostly due to HELLP syndrome, delay in diagnoses and cerebrovascular hemorrhage [9] . Maternal mortality rate is between 1.1 and 3.4%.Dic found in 4-38%, hepatic rapture found in 1.8% and considered most serious complication of HELLP syndrome [10] . BMI >30, antenatal hypertensive diseases, cesarean delivery and African American race all are predictive of readmission for postpartum eclampsia.
Risk factors for the development of new-onset late postpartum preeclampsia (LPP) in women without any history of preeclampsia are not known. Because identification of women at risk may lead to earlier diagnosis of disease and improved maternal outcomes [11, 12] . No recent study has been carried out in our population so the purpose of this study is to determine the frequency of mortality and obstetrical factors associated with maternal mortality in patient with postpartum eclampsia.
Methodology

Setting
Department of obstetrics & gynecology LUMHS Hospital Hyderabad
Study Design
Descriptive case series Sample size: 63 By using WHO Sample Size Calculator using maternal mortality in postpartum eclampsia 3.4%, d=Margin of error=2% CI=confidence level =95%, then estimated sample size was n=316.
Sample technique
Non probability-consecutive 
Data Collection
All patients of postpartum eclampsia with increase blood pressure and proteinuria admitted throughout patient department or emergency within 48 hours of delivery were included in the study. Patients were followed for 10 days. Informed written informed consent was taken from the patient/ guardian. Data were entered on predesigned proforma which includes Demographic details, frequency of mortality in patients with postpartum eclampsia and obstetrical factors associated with maternal mortality in patient with postpartum eclampsia.
Data Analysis
Data was analyzed by using SSPS version 16. Mean and standard deviation were calculated for continuous variables like age, systolic blood pressure and urine protein. Frequencies and percentage were calculated for categorical variables like parity, eclampsia, chronic hypertension and pre-eclampsia. Effect modifier like age, parity, was consolidated through stratification. Post stratification chi square test was applied P ≤ 0.05 was taken as significant.
Result
In this study 316 pregnant women with age range of 20-45 were included in this study through non-probability consecutive sampling. Mean ± SD of age was 27.88±7.77 with C.I (27.02…….28.74) years as shown in Table 4 Out of 369 19 (6%) women were found to be chronic hypertensive as shown in Figure 1 Most of the women 263 (83%) were found to be Pre-Eclamptic as shown in Figure 2 Positive Eclampsia was found in 301 (95%) women as shown in Figure 3 Out of 369 mortality was occur in 190 (60%) women as shown in Figure 4 Stratification of mortality was done with respect to age, systolic .P, Urine Protein, Parity, Chronic HTN, Preeclampsia and Eclampsia shown from ( 
Discussion
Early postpartum preeclampsia/eclampsia has been well recognized for decades as the slow resolution of a patho-physiologic process that began during pregnancy and was theoretically "cured" by delivery. Late (> 48h) postpartum preeclampsia has been viewed with more skepticism. Today, the postpartum days that define the outer limit of preeclampsia/eclampsia are not known, but are conventionally extended into the fourth week post-partum [13] . In recent series, postpartum eclampsia accounts for approximately 11-of all eclamptic cases [14] .
In one 10-year retrospective case series, the incidence of preeclampsia in the postpartum period was found to be 5.7% [15] . Of these, 15.9% went on to develop eclampsia. Due to the risk of progression to seizures, early recognition of warning signs and symptoms followed by prompt and appropriate treatment is important. The availability of prenatal care, combined with early recognition and effective management of preeclampsia, has resulted in a decrease in the incidence of antepartum and early postpartum eclampsia. In one recent study, 79% of postpartum eclampsia cases occurred more than 48 h after delivery *16+. It is this "late" presentation of the disease, usually occurring after obstetric discharge and often without prior diagnosis pre-or peripartum, which requires ED recognition and skill at management.
According to WHO, maternal death means "death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and the site of pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes". Death records remain an important source of maternal deaths. Using death certificate as sole source suffers from drawback because many times cause of death is not mentioned, especially if death incurred medicolegal autopsy. Often only cardiorespiratory arrest was furnished as a cause of death. In past, studies had shown that physicians completing death records fol-lowing a maternal death fail to report that the woman was pregnant or had recent pregnancy in 50% or more of these cases [17] .
In our study, majority of patients had age group 20-30 years (73.73%) followed by age group 51-75 years (26.26%). In present study 72% mortality was occur in women in age group of (18) years This finding supported by the study conducted by Sirjusingh A et al. [17] , which shows that the commonest age of mortality is between 20 to 30 years with mean age of 28 years old.
In our study mean of women was 27.88±7.77 which is comparable with the results obtained; who reported the mean age of 28.76±9.28 years. Similar results were also obtained by Helewa ME [18] . In present study significant association was found between Urine Protein, Parity, Preeclampsia with mortality i.e.(P<0.05) and highly significant association was systolic BP and mortality i.e. (P<0.0001). This might be due to increased frequency of mortality in between (19) years of age. Sibai BM in his study also observed that most of the mortality occurs in women with age group of (31-43) years [20] . Walling AD observed similar results in a study conducted in America [21] .
Strength of our study was use of consecutive sampling best suited for our study design and sample selection, as our inclusion and exclusion criteria was stringent. The use of objective definitions for predictor and outcome variable also minimizes the source of bias in our study. The main limitations of our study were use of a weak study design case series the analysis and strength of evidence of which is limited and therefore the study design does not require any prior sample size calculation. Also limited outcomes selected in our study affects the worth of our study. There were many variables and factors that have association with our predictor and outcome variables that could have been included in our study. The use of non-probability sampling also limits generalizability; however we had a small number of patients and besides the follow up duration are short.
This study was hospital-based study; hence the figure does not reflect true frequency and severity of the disease. Moreover, the study was conducted in one unit in single hospital which further confine its generalization.
Conclusion
It is to be concluded that mortality is most in eclampctic women followed by patients with Pre-eclampsia. However a study design comprising multiple centers and a higher number of patients over a longer period of time will be more representative. It will also nullify any regional bias due to fewer centers of treatment. Our research findings are useful for prioritizing future childhood cancer research needs.
